FindTrial
Sign In

A study to find out insights details about Extranodal Follicular Dendritic Cell Sarcomas a type of rare cancer found outside lymph nodes from our experience at a major cancer hospital in india

Extranodal Follicular Dendritic Cell Sarcomas and their Oligorecurrences: Lessons learnt at a Single Tertiary Cancer Referral Centre, India - NA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/11/097108
Enrollment
14
Registered
2025-11-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C964- Sarcoma of dendritic cells (accessory cells)

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Consecutive adult patients 18 years of both sexes with patients with ENFDCS with or without recurrence. 2. Date of surgery between 1st January 2011 to 31st December 2024.

Exclusion criteria

Exclusion criteria: Date of surgery outside the study period.

Design outcomes

Primary

MeasureTime frame
Median overall survival (OS) will be calculated from the date of surgery until last follow-up or death, and disease-free survival (DFS) will be evaluated from the day of surgery to the first follow-up visit that revealed tumor recurrence.Timepoint: 6 months—

Secondary

MeasureTime frame
NILTimepoint: NIL;Evaluation of factors influencing the outcomes and recurrence in patients with ENFDCSTimepoint: 6 months—

Countries

India

Contacts

Public ContactDr SHRADDHA PATKAR

Tata Memorial Hospital, Mumbai

drshraddhapatkar@gmail.com9820074818

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026